KRIBIOLISA™ Rituximab ELISA
The Rituximab ELISA kit is intended for the quantitative determination of Rituximab in serum, plasma and cell culture samples. Validated against International NIBSC standards by WHO.
Receive your quote directly from the manufacturer.
Assay Background:
Rituximab is a genetically engineered chimeric murine / human monoclonal IgG1 kappa antibody directed against the CD20 antigen, which is primarily found on the surface of B cells. Rituximab is used in the treatment of many lymphomas, leukemias, transplant rejection and some autoimmune disorders. Unwanted immunogenicity from rituximab can manifest itself through anti-drug antibody (ADA) responses. ADA responses can lead to allergic reactions, reduction or neutralization of the activity of the drug and in some cases cross-reactive immune responses, which could lead to serious adverse events.
- Calibrator Range: 0 ng/ml - 640 ng/ml
- Sensitivity: 9.4 ng/ml
- Sample Type: Serum and Plasma
- Reactivity: Human
- Shipping Condition: 2 - 8 Deg C
- Detection Method: Colorimetric
- Usage: For In-Vitro Diagnostic Use (CE IVD); RUO available on request
- Research Area: Immunotherapy Therapeutic Drug Monitoring Cancer
About the Rituximab ELISA kit:
- Uses anti-idiotypic antibodies sourced from our vendor partner in the US, which ensures higher specificity, and low cross reactivity
- Recovery rates are 80 - 120%
- Validated as per US FDA guidelines for Bioassays
- Optimized for matrix effects to ensure higher sensitivity
- Uses the innovator drug as calibrator, and is optimized for biosimilars studies
